| scholarly article | Q13442814 |
| P50 | author | Tongxiang Lin | Q42873996 |
| P2093 | author name string | Yang Xu | |
| Wei Gu | |||
| Hiroaki Uranishi | |||
| Lijin Feng | |||
| P2860 | cites work | Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization | Q24292930 |
| Regulation of p53 activity through lysine methylation | Q24311514 | ||
| Mdm2 promotes the rapid degradation of p53 | Q24322597 | ||
| Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 | Q24328775 | ||
| SUMO-1 modification activates the transcriptional response of p53 | Q24529948 | ||
| p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage | Q24530584 | ||
| Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment | Q52590496 | ||
| Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases | Q77456357 | ||
| Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain | Q27860534 | ||
| Regulation of p53 stability by Mdm2 | Q27860744 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| Surfing the p53 network | Q28032484 | ||
| Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. | Q28117154 | ||
| The ubiquitin ligase COP1 is a critical negative regulator of p53 | Q28258057 | ||
| Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity | Q28270986 | ||
| ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins | Q28273233 | ||
| p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression | Q28300071 | ||
| p53 mutations in human cancers | Q28302973 | ||
| Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation | Q28609772 | ||
| Live or let die: the cell's response to p53 | Q29547663 | ||
| Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors | Q29614306 | ||
| Post-translational modifications and activation of p53 by genotoxic stresses | Q29615659 | ||
| DNA damage activates p53 through a phosphorylation–acetylation cascade | Q29616294 | ||
| p53: puzzle and paradigm | Q29618407 | ||
| Regulation of Mdm2-Directed Degradation by the C Terminus of p53 | Q33779929 | ||
| Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo | Q33896638 | ||
| Signaling to p53: breaking the posttranslational modification code | Q33945840 | ||
| Mutation of mouse p53 Ser23 and the response to DNA damage | Q34277066 | ||
| Putting the stress on senescence | Q34430830 | ||
| p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. | Q34585107 | ||
| Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation | Q35089377 | ||
| Regulation of p53 responses by post-translational modifications | Q35116637 | ||
| p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage | Q35123816 | ||
| Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage | Q35352915 | ||
| The p53 response to DNA damage | Q35848498 | ||
| Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo | Q36601373 | ||
| Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses | Q38351593 | ||
| Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation | Q39540070 | ||
| Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination | Q39540284 | ||
| How phosphorylation regulates the activity of p53. | Q41206472 | ||
| p53 heterozygosity alters the mRNA expression of p53 target genes in the bone marrow in response to inhaled benzene | Q43918887 | ||
| Acetylation of p53 inhibits its ubiquitination by Mdm2. | Q44209228 | ||
| p53 linear diffusion along DNA requires its C terminus | Q45138454 | ||
| Essential roles of the kappa light chain intronic enhancer and 3' enhancer in kappa rearrangement and demethylation | Q46053556 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5389-5395 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity | |
| P478 | volume | 25 |
| Q37249372 | A complex barcode underlies the heterogeneous response of p53 to stress |
| Q36883420 | A method to study the expression of DNA methyltransferases in aging systems in vitro |
| Q24313477 | Acetylation is indispensable for p53 activation |
| Q36333610 | Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity. |
| Q27667596 | Acetylation of lysine 120 of p53 endows DNA-binding specificity at effective physiological salt concentration |
| Q34281034 | Acetylation of malate dehydrogenase 1 promotes adipogenic differentiation via activating its enzymatic activity |
| Q35071254 | Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage |
| Q34520098 | Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). |
| Q37132255 | Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer |
| Q37676920 | Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode |
| Q45580447 | Apoptosis regulator proteins: basis for the development of innovation strategies for the treatment of rheumatoid arthritis in patients of different age. |
| Q53025209 | ArhGAP30 promotes p53 acetylation and function in colorectal cancer |
| Q35803035 | Back to your heart: ubiquitin proteasome system-regulated signal transduction |
| Q34099075 | Bioinformatic Analysis and Post-Translational Modification Crosstalk Prediction of Lysine Acetylation |
| Q40157263 | C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. |
| Q40060471 | COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1. |
| Q42153052 | Chemical and functional aspects of posttranslational modification of proteins |
| Q41497840 | Comparative mitochondrial proteomic, physiological, biochemical and ultrastructural profiling reveal factors underpinning salt tolerance in tetraploid black locust (Robinia pseudoacacia L.). |
| Q36856933 | Conditional mutation of Smc5 in mouse embryonic stem cells perturbs condensin localization and mitotic progression |
| Q34614596 | Crippling p53 activities via knock-in mutations in mouse models |
| Q24311663 | Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding |
| Q63379340 | De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome |
| Q36430180 | Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice |
| Q36908396 | Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. |
| Q34857637 | Dynamic protein methylation in chromatin biology |
| Q39936932 | E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes |
| Q51186530 | Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains |
| Q34488832 | Effects of ethylene glycol monomethyl ether and its metabolite, 2-methoxyacetic acid, on organogenesis stage mouse limbs in vitro |
| Q34251168 | Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53 |
| Q33278013 | Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1. |
| Q40318351 | Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function |
| Q37428803 | Extensive post-translational modification of active and inactivated forms of endogenous p53. |
| Q35098597 | Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity |
| Q33857604 | Functional analysis of the acetylation of human p53 in DNA damage responses |
| Q24298004 | G9a and Glp methylate lysine 373 in the tumor suppressor p53 |
| Q33788833 | Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk |
| Q34534169 | Green Tea Polyphenols Induce p53-Dependent and p53-Independent Apoptosis in Prostate Cancer Cells through Two Distinct Mechanisms |
| Q24301527 | HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53 |
| Q28082536 | Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy |
| Q35893218 | Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology |
| Q38217666 | Histone deacetylase inhibitors and cell death |
| Q28240447 | Histone deacetylases and cancer |
| Q35091367 | Hodgkin lymphoma risk: Role of genetic polymorphisms and gene–gene interactions in DNA repair pathways |
| Q33802917 | How does SIRT1 affect metabolism, senescence and cancer? |
| Q36879036 | How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? |
| Q38176221 | Illuminating p53 function in cancer with genetically engineered mouse models |
| Q34042319 | In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models |
| Q45306567 | Increased caspase-2, calpain activations and decreased mitochondrial complex II activity in cells expressing exogenous huntingtin exon 1 containing CAG repeat in the pathogenic range |
| Q40340028 | Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage |
| Q41667065 | Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation |
| Q64261584 | Inhibition of nucleolar stress response by Sirt1: A potential mechanism of acetylation-independent regulation of p53 accumulation |
| Q35633551 | Inhibition of p53 acetylation by INHAT subunit SET/TAF-Iβ represses p53 activity |
| Q38177769 | Insights into wild-type and mutant p53 functions provided by genetically engineered mice |
| Q39414955 | Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53 |
| Q34342940 | Limiting the power of p53 through the ubiquitin proteasome pathway |
| Q24644959 | Lysine acetylation: codified crosstalk with other posttranslational modifications |
| Q37970950 | Lysine methylation: beyond histones |
| Q39912357 | MSL2 promotes Mdm2-independent cytoplasmic localization of p53 |
| Q34503497 | Making sense of ubiquitin ligases that regulate p53 |
| Q39646906 | Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technology |
| Q47416965 | Mechanisms of transcriptional regulation by p53. |
| Q33252515 | Microarray analysis of differentially expressed genes in mouse bone marrow tissues after ionizing radiation |
| Q29615657 | Modes of p53 regulation |
| Q40423291 | Modification of Drosophila p53 by SUMO modulates its transactivation and pro-apoptotic functions. |
| Q42810240 | Modulation of lysine acetylation-stimulated repressive activity by Erk2-mediated phosphorylation of RIP140 in adipocyte differentiation |
| Q24337822 | Modulation of p53 function by SET8-mediated methylation at lysine 382 |
| Q39298346 | Monoubiquitination joins polyubiquitination as an esteemed proteasomal targeting signal |
| Q36436702 | Mouse bites dogma: how mouse models are changing our views of how P53 is regulated in vivo |
| Q39455093 | Mule determines the apoptotic response to HDAC inhibitors by targeted ubiquitination and destruction of HDAC2. |
| Q46970010 | Multienzyme assembly of a p53 transcription complex |
| Q33818479 | Mutant TP53 posttranslational modifications: challenges and opportunities. |
| Q34758670 | New insights into p53 activation |
| Q38316390 | Nucleolar protein, Myb-binding protein 1A, specifically binds to nonacetylated p53 and efficiently promotes transcriptional activation |
| Q38824781 | Nucleolus-derived mediators in oncogenic stress response and activation of p53-dependent pathways |
| Q79916949 | P53 gene mutations in pituitary carcinomas |
| Q37235547 | PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression |
| Q33899450 | Posttranslational modification of p53: cooperative integrators of function |
| Q36379368 | Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML. |
| Q35927931 | Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation |
| Q36685003 | Quantitative proteomics analysis of the effects of ionizing radiation in wild type and p53 K317R knock-in mouse thymocytes |
| Q33886284 | Rapid temporal control of Foxp3 protein degradation by sirtuin-1. |
| Q27665584 | Recognition and Specificity Determinants of the Human Cbx Chromodomains |
| Q34498137 | Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system |
| Q29615658 | Regulating the p53 pathway: in vitro hypotheses, in vivo veritas |
| Q96348276 | Regulating tumor suppressor genes: post-translational modifications |
| Q37957713 | Regulation of p53 by ING family members in suppression of tumor initiation and progression |
| Q37636014 | Regulation of p53--insights into a complex process |
| Q29976922 | Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11 |
| Q36733743 | Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway |
| Q35075426 | Retracted: Residues 240-250 in the C-Terminus of the Pirh2 Protein Complement the Function of the RING Domain in Self-Ubiquitination of the Pirh2 Protein |
| Q39608666 | Rotavirus Replication Requires a Functional Proteasome for Effective Assembly of Viroplasms |
| Q24674602 | SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation |
| Q38223674 | SUMOylation in Drosophila Development |
| Q24645289 | SUMOylation of pontin chromatin-remodeling complex reveals a signal integration code in prostate cancer cells |
| Q36908428 | Sirtuins: critical regulators at the crossroads between cancer and aging |
| Q27675200 | Structural Basis for Specific Binding of Human MPP8 Chromodomain to Histone H3 Methylated at Lysine 9 |
| Q37068706 | Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry? |
| Q35629831 | Targeting protein lysine methylation and demethylation in cancers. |
| Q38996247 | Tetramerization-defects of p53 result in aberrant ubiquitylation and transcriptional activity |
| Q28507164 | The C terminus of p53 regulates gene expression by multiple mechanisms in a target- and tissue-specific manner in vivo |
| Q28088295 | The Role of Histone Acetyltransferases in Normal and Malignant Hematopoiesis |
| Q38964688 | The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein. |
| Q42557316 | The WTX Tumor Suppressor Enhances p53 Acetylation by CBP/p300 |
| Q34692752 | The biology of lysine acetylation integrates transcriptional programming and metabolism |
| Q34199692 | The impact of acetylation and deacetylation on the p53 pathway |
| Q92062954 | The multiple mechanisms that regulate p53 activity and cell fate |
| Q37596345 | The nucleolar protein Myb-binding protein 1A (MYBBP1A) enhances p53 tetramerization and acetylation in response to nucleolar disruption |
| Q58430752 | The p53 C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domain |
| Q39367419 | The p53 isoforms are differentially modified by Mdm2. |
| Q34020353 | The p53 orchestra: Mdm2 and Mdmx set the tone |
| Q52614614 | The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations |
| Q33980004 | Time-course transcriptional profiling of human amniotic fluid-derived stem cells using microarray |
| Q41973686 | Tip60-mediated acetylation activates transcription independent apoptotic activity of Abl. |
| Q37621004 | Transactivation of bad by vorinostat-induced acetylated p53 enhances doxorubicin-induced cytotoxicity in cervical cancer cells. |
| Q36436698 | Transcriptional regulation by p53: one protein, many possibilities |
| Q43120565 | Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence |
| Q36538525 | UBE4B: A Promising Regulatory Molecule in Neuronal Death and Survival |
| Q36974861 | USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2. |
| Q83165587 | Ubiquitin Family Members in the Regulation of the Tumor Suppressor p53 |
| Q24608267 | Vienna-PTM web server: a toolkit for MD simulations of protein post-translational modifications |
| Q34683053 | X-chromosome targeting and dosage compensation are mediated by distinct domains in MSL-3. |
| Q40015788 | hAda3 degradation by papillomavirus type 16 E6 correlates with abrogation of the p14ARF-p53 pathway and efficient immortalization of human mammary epithelial cells |
| Q28085076 | p53 Acetylation: Regulation and Consequences |
| Q36088355 | p53 RNA interactions: new clues in an old mystery |
| Q36052576 | p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes |
| Q79306638 | p53 downstream target genes and tumor suppression: a classical view in evolution |
| Q34300569 | p53 post-translational modification: deregulated in tumorigenesis |
| Q37882073 | p53 regulation by ubiquitin |
| Q36567469 | p53 sumoylation: mechanistic insights from reconstitution studies |
| Q27302884 | p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion |
| Q29619502 | p53 ubiquitination: Mdm2 and beyond |
| Q28590571 | p85α mediates p53 K370 acetylation by p300 and regulates its promoter-specific transactivity in the cellular UVB response |
Search more.